SCHEMBL8600138

SCHEMBL8600138

COc1ccc(-c2cc(-c3cccc(COS(C)(=O)=O)n3)nc(-c3cccc(COS(C)(=O)=O)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.41
LTB4R Q15722 2/20 0.39
MCL1 Q07820 2/20 0.39
ABL1 P00519 1/20 0.38
ABCB1 P08183 1/20 0.38
BCR P11274 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
MPO P05164 1/20 0.38
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPK1 P28482 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7770338 0.92 FFAR1 (0.43) PDE10ALTB4RADORA3NPC1RAB9A
SCHEMBL8935757 0.83 ADORA3 (0.43) PDE10ALTB4RMCL1ABL1ABCB1
SCHEMBL7847605 0.79 ABL1 (0.44) PDE10AMCL1ABL1ABCB1BCR
SCHEMBL8596986 0.79 ABL1 (0.44) PDE10ALTB4RMCL1ABL1ABCB1
SCHEMBL7770337 0.77 ADORA3 (0.43) ADORA3NPC1RAB9AKMT2ASYK
SCHEMBL12137368 0.74 MEN1 (0.46) PDE10ATP53RAB9AMAPK1KDM4E
SCHEMBL8765283 0.74 MCL1 (0.45) LTB4RMCL1ADORA3TP53SMN1; SMN2
SCHEMBL25321212 0.73 KCNH2 (0.44) KDM4EALDH1A1NPSR1USP2
SCHEMBL8935842 0.73 ALDH1A1 (0.47) LTB4RMCL1ADORA3SMN1; SMN2NPC1
SCHEMBL2082694 0.72 KDM4E (0.49) PDE10ATP53SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5707603-A Pyridine complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions NYCOMED IMAGING AS (NO) 1998-01-13 US disclosed
US-5539117-A 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines GE HEALTHCARE AS (NO) 1996-07-23 US disclosed
EP-0639083-A1 COMPLEXING AGENTS AND TARGETING IMMUNOREAGENTS NYCOMED IMAGING AS (NO) 1995-02-22 EP disclosed
US-5350696-A 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines STERLING WINTHROP, INC. (US) 1994-09-27 US disclosed
WO-1993021957-A1 COMPLEXING AGENTS AND TARGETING IMMUNOREAGENTS STERLING WINTHROP INC. (US) 1993-11-11 WO disclosed